Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.
Pancreatic proteases in the duodenum inhibit the release of cholecystokinin (CCK) and thus exert feedback control of pancreatic exocrine secretion. Exclusion of proteases from the duodenum either by the diversion of bile-pancreatic juice or by the addition of protease inhibitors stimulates exocrine...
Gardado en:
| Publicado en: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
National Academy of Sciences
1996
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC38851/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8755579/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.15.7927 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|